Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare

BACKGROUND: Substantial evidence indicates that delay of first treatment after diagnosis is associated with poorer survival outcomes in breast cancer. Accordingly, the Commission on Cancer introduced a quality measure for receipt of therapeutic surgery within 60 days of diagnostic biopsy for stage I...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Rashmi, Leslie, Macall, Dondapati, Priya, Davis, Rachel, Tanaka, Kenichi, Jett, Elizabeth, Chervoneva, Inna, Tanaka, Takemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284985/
https://www.ncbi.nlm.nih.gov/pubmed/37130988
http://dx.doi.org/10.1007/s12282-023-01456-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284985/
https://www.ncbi.nlm.nih.gov/pubmed/37130988
http://dx.doi.org/10.1007/s12282-023-01456-3

Ejemplares similares